You are here:
Ocaliva: review started
2023.10.13
Active substance: obeticholic acid
13.10.2023 - Procedure started
EMA’s human medicines committee (CHMP) has started a review of the medicine Ocaliva (obeticholic acid), used to treat adults with primary biliary cholangitis (PBC).
Further information
For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):